Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D

NCT04074421 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

IBS - Irritable Bowel Syndrome
Gut Microbiota

Interventions

DRUG: Rifaximin
DRUG: Probiotic Formula
DRUG: Placebo oral tablet

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]